Ahmed S Bayoumi1, Kyoung-Mi Park1, Yongchao Wang1, Jian-Peng Teoh1, Tatsuya Aonuma1, Yaoliang Tang2, Huabo Su3, Neal L Weintraub2, Il-Man Kim4. 1. Vascular Biology Center, USA. 2. Vascular Biology Center, USA; Department of Medicine, USA. 3. Vascular Biology Center, USA; Department of Pharmacology and Toxicology, USA. 4. Vascular Biology Center, USA; Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, GA, USA. Electronic address: ilkim@augusta.edu.
Abstract
BACKGROUND: Cardiac injury is accompanied by dynamic changes in the expression of microRNAs (miRs), small non-coding RNAs that post-transcriptionally regulate target genes. MiR-125b-5p is downregulated in patients with end-stage dilated and ischemic cardiomyopathy, and has been proposed as a biomarker of heart failure. We previously reported that the β-blocker carvedilol promotes cardioprotection via β-arrestin-biased agonism of β1-adrenergic receptor while stimulating miR-125b-5p processing in the mouse heart. We hypothesize that β1-adrenergic receptor/β-arrestin1-responsive miR-125b-5p confers the improvement of cardiac function and structure after acute myocardial infarction. METHODS AND RESULTS: Using cultured cardiomyocyte (CM) and in vivo approaches, we show that miR-125b-5p is an ischemic stress-responsive protector against CM apoptosis. CMs lacking miR-125b-5p exhibit increased susceptibility to stress-induced apoptosis, while CMs overexpressing miR-125b-5p have increased phospho-AKT pro-survival signaling. Moreover, we demonstrate that loss-of-function of miR-125b-5p in the mouse heart causes abnormalities in cardiac structure and function after acute myocardial infarction. Mechanistically, the improvement of cardiac function and structure elicited by miR-125b-5p is in part attributed to repression of the pro-apoptotic genes Bak1 and Klf13 in CMs. CONCLUSIONS: In conclusion, these findings reveal a pivotal role for miR-125b-5p in regulating CM survival during acute myocardial infarction.
BACKGROUND:Cardiac injury is accompanied by dynamic changes in the expression of microRNAs (miRs), small non-coding RNAs that post-transcriptionally regulate target genes. MiR-125b-5p is downregulated in patients with end-stage dilated and ischemic cardiomyopathy, and has been proposed as a biomarker of heart failure. We previously reported that the β-blocker carvedilol promotes cardioprotection via β-arrestin-biased agonism of β1-adrenergic receptor while stimulating miR-125b-5p processing in the mouse heart. We hypothesize that β1-adrenergic receptor/β-arrestin1-responsive miR-125b-5p confers the improvement of cardiac function and structure after acute myocardial infarction. METHODS AND RESULTS: Using cultured cardiomyocyte (CM) and in vivo approaches, we show that miR-125b-5p is an ischemic stress-responsive protector against CM apoptosis. CMs lacking miR-125b-5p exhibit increased susceptibility to stress-induced apoptosis, while CMs overexpressing miR-125b-5p have increased phospho-AKT pro-survival signaling. Moreover, we demonstrate that loss-of-function of miR-125b-5p in the mouse heart causes abnormalities in cardiac structure and function after acute myocardial infarction. Mechanistically, the improvement of cardiac function and structure elicited by miR-125b-5p is in part attributed to repression of the pro-apoptotic genes Bak1 and Klf13 in CMs. CONCLUSIONS: In conclusion, these findings reveal a pivotal role for miR-125b-5p in regulating CM survival during acute myocardial infarction.
Authors: Il-Man Kim; Timothy Ackerson; Sneha Ramakrishna; Maria Tretiakova; I-Ching Wang; Tanya V Kalin; Michael L Major; Galina A Gusarova; Helena M Yoder; Robert H Costa; Vladimir V Kalinichenko Journal: Cancer Res Date: 2006-02-15 Impact factor: 12.701
Authors: Suli Huang; Mu Chen; Lu Li; Mei'an He; Die Hu; Xiaomin Zhang; Jun Li; Robert M Tanguay; Jing Feng; Longxian Cheng; Hesong Zeng; Xiayun Dai; Qifei Deng; Frank B Hu; Tangchun Wu Journal: Circ Cardiovasc Genet Date: 2014-03-13
Authors: Zoltán V Varga; Agnes Zvara; Nóra Faragó; Gabriella F Kocsis; Márton Pipicz; Renáta Gáspár; Péter Bencsik; Anikó Görbe; Csaba Csonka; László G Puskás; Thomas Thum; Tamás Csont; Péter Ferdinandy Journal: Am J Physiol Heart Circ Physiol Date: 2014-05-23 Impact factor: 4.733
Authors: Praphulla C Shukla; Krishna K Singh; Adrian Quan; Mohammed Al-Omran; Hwee Teoh; Fina Lovren; Liu Cao; Ilsa I Rovira; Yi Pan; Christine Brezden-Masley; Bobby Yanagawa; Aanika Gupta; Chu-Xia Deng; John G Coles; Howard Leong-Poi; William L Stanford; Thomas G Parker; Michael D Schneider; Toren Finkel; Subodh Verma Journal: Nat Commun Date: 2011-12-20 Impact factor: 14.919
Authors: Alessandra Castaldi; Tania Zaglia; Vittoria Di Mauro; Pierluigi Carullo; Giacomo Viggiani; Giulia Borile; Barbara Di Stefano; Gabriele Giacomo Schiattarella; Maria Giovanna Gualazzi; Leonardo Elia; Giuliano Giuseppe Stirparo; Maria Luisa Colorito; Gianluigi Pironti; Paolo Kunderfranco; Giovanni Esposito; Marie-Louise Bang; Marco Mongillo; Gianluigi Condorelli; Daniele Catalucci Journal: Circ Res Date: 2014-05-07 Impact factor: 17.367
Authors: Maryam Syed; Jana P Ball; Keisa W Mathis; Michael E Hall; Michael J Ryan; Marc E Rothenberg; Licy L Yanes Cardozo; Damian G Romero Journal: Am J Physiol Endocrinol Metab Date: 2018-08-28 Impact factor: 4.310